Annals of Pediatric Endocrinology & Metabolism, 24 (2), 92-98
Oral BPC-157 Peptide Therapy fills the role none of these other treatments can: sustained, systemic daily healing support
BPC157 also appears in studies to play a key role in protecting the gastrointestinal lining, and gut-wall integrity, with research into gutbrain interactions, making it of particular interest in clinical trials related to managing leaky gut, Crohns disease, and NSAID-induced ulcers
It is not approved as a drug, supplement, or food ingredient in the US, EU, Australia, and similar markets
Understanding the differences and similarities between TB 500 and BPC 157 can help in making informed decisions